Stryker Corp (SYK)
328.45
+1.82
(+0.56%)
USD |
NYSE |
May 03, 16:00
328.37
-0.08
(-0.02%)
After-Hours: 20:00
Stryker Cash from Operations (Annual): 3.711B for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 3.711B |
December 31, 2022 | 2.624B |
December 31, 2021 | 3.263B |
December 31, 2020 | 3.277B |
December 31, 2019 | 2.191B |
December 31, 2018 | 2.61B |
December 31, 2017 | 1.559B |
December 31, 2016 | 1.915B |
December 31, 2015 | 981.00M |
December 31, 2014 | 1.782B |
December 31, 2013 | 1.886B |
December 31, 2012 | 1.657B |
December 31, 2011 | 1.434B |
December 31, 2010 | 1.547B |
December 31, 2009 | 1.461B |
December 31, 2008 | 1.176B |
December 31, 2007 | 1.028B |
December 31, 2006 | 867.30M |
Date | Value |
---|---|
December 31, 2005 | 833.40M |
December 31, 2004 | 559.50M |
December 31, 2003 | 648.50M |
December 31, 2002 | 516.20M |
December 31, 2001 | 473.20M |
December 31, 2000 | 333.00M |
December 31, 1999 | 284.00M |
December 31, 1998 | 154.50M |
December 31, 1997 | 91.90M |
December 31, 1996 | 204.30M |
December 31, 1995 | 111.50M |
December 31, 1994 | 97.70M |
December 31, 1993 | 86.10M |
December 31, 1992 | 50.70M |
December 31, 1991 | 37.60M |
December 31, 1990 | 48.30M |
December 31, 1989 | 21.50M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
2.191B
Minimum
2019
3.711B
Maximum
2023
3.013B
Average
3.263B
Median
2021
Cash from Operations (Annual) Benchmarks
Boston Scientific Corp | 2.503B |
Haemonetics Corp | 273.06M |
Abbott Laboratories | 7.261B |
Zimmer Biomet Holdings Inc | 1.582B |
ResMed Inc | 693.30M |